Table 2.
DAY 7 | EAM (n = 12) | Control (n = 10) | P‐value | DAY 21 | EAM (n = 12) | Control (n = 10) | P‐value | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Median | IQR | Median | IQR | Median | IQR | Median | IQR | ||||
LVIDd (mm) | 3.6 | 3.4‐3.9 | 3.3 | 3.2‐3.6 | 0.028 | LVIDd (mm) | 5.8 | 4.8‐6.0 | 5.0 | 4.6‐5.3 | 0.0515 |
LVIDs (mm) | 2.3 | 2.2‐2.5 | 2.1 | 2.1‐2.3 | 0.041 | LVIDs (mm) | 3.8 | 3.3‐3.9 | 3.4 | 2.9‐3.7 | 0.0443 |
EF (%) | 65.2 | 62.7‐69.1 | 67.0 | 63.7‐71.5 | 0.508 | EF (%) | 62.3 | 56.8‐64.0 | 58.7 | 55.9‐63.6 | 0.4483 |
LV‐mass (mg) | 127.3 | 112.5‐152.8 | 100.4 | 92.0‐115.8 | 0.012 | LV‐mass (mg) | 426.8 | 281.0‐442.1 | 266.3 | 205.2‐302.4 | 0.0161 |
(n = 11) | % | (n = 8) | % | (n = 11) | % | (n = 10) | % | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Diastolic dysf.: 0 | 4 | 36.36 | 3 | 37.5 | 0.943 | Diastolic dysf.: 0 | 5 | 45.45 | 4 | 40 | 0.969 |
1 | 5 | 45.45 | 4 | 50 | 1 | 2 | 18.18 | 2 | 20 | ||
>2 | 2 | 18.18 | 1 | 12.5 | >2 | 4 | 36.36 | 4 | 40 |